Category: Global trials
Reflections from ESMO 2025 Progress, Breakthrough Science and the Future of Oncology We were delighted to attend the recent Read Now
Advancing Lung Cancer Trials with Precision Lung cancer is the second most diagnosed cancer and the leading cause of cancer-related deaths Read Now
Best Practices for Operationalizing Global, Early-Phase Oncology Trials The early-phase oncology clinical trial landscape is constantly evolving, influenced by shifts in regulatory guidance Read Now
FDA Issues Draft Guidance on Conducting Multiregional Oncology Trials Clinical regulation helps enable consistent study results Oncology trials are becoming more global. While 22% Read Now